Zinc lozenges as cure for the common cold - A review and hypothesis

Medical Hypotheses

Volumn 74, Issue 3, 2010, Pages 482-492

  Eby, George A ^a  

^a George Eby Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCONATE ZINC; INTERCELLULAR ADHESION MOLECULE 1; PLACEBO; ZINC; ZINC ACETATE;

ARTICLE; CLINICAL TRIAL; COMMON COLD; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG RESPONSE; DRUG STABILITY; EFFERVESCENT TABLET; HUMAN; IN VITRO STUDY; LOZENGE; PH MEASUREMENT; RHINOVIRUS;

BIOLOGICAL AVAILABILITY; CLINICAL TRIALS AS TOPIC; COMMON COLD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; TABLETS; ZINC;

RHINOVIRUS;

EID: 77649271498     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.10.017     Document Type: Article

References (81)

1. Fendrick A.M., Monto A.S., Nightengale B., et al. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003, 163:487-494.
2. Korant B.D., Butterworth B.E. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol 1976, 18:298-306.
3. Korant B.D., Kaurer J.C., Butterworth B.E. Zinc ions inhibit replication of rhinoviruses. Nature 1974, 248:588-590.
4. Butterworth B.E., Grunert R.R., Korant B.D., et al. Replication of rhinoviruses. Arch Virol 1976, 51:169-189.
5. Korant B.D., Butterworth B.E. Inhibition by zinc of rhinovirus protein cleavage. Interaction of zinc with capsid polypeptides. Chem Abstr 1976, 85:76. Abs. 85:814y.
6. Korant B.D. Role of cellular and viral proteases in the processing of picornavirus proteins. The molecular biology of picornaviruses 1979, Plenum Publishing, New York. R. Perez-Bercoff (Ed.).
7. Korant B.D. Inhibition of viral protein cleavage. Design of inhibitors of viral functions 1979, Academic Press, New York. K.K. Gauri (Ed.).
8. Butterworth B.E., Korant B.D. Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol 1974, 14:282-291.
9. Korant B.D., Kauer J.C., Butterworth B.E. Molecular basis of zinc as a viral inhibitor. Ultratrace metal analysis in biological sciences and environment 1979, American Chemical Society, Washington, DC. T.H. Risby (Ed.).
10. Merluzzi V.J., Cipriano D., McNeil D., et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Res Commun Chem Pathol Pharmacol 1989, 66:425-440.
11. Prasad A.S., Beck F.W.J., Bao B., Snell D., Fitzgerald J.T. Duration and severity of symptoms and levels of plasma Interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis 2008, 197:795-802.
12. Driessen C., Hirv K., Kirchner H., Rink L. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology 1995, 84:272-277.
13. Berg K., Bolt G., Andersen H., Owen T.C. Zinc potentiates the antiviral action of human IFN-alpha tenfold. J Interf Cytok Res 2001, 21:471-474.
14. Marone G., Columbo A., De Paulis A., Cirillo R., Giugliano R., Condorelli M. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents Actions 1986, 18:103-106.
15. 2+. Bioscience Rep 1987, 7:81-91.
16. Eby GA. Handbook for curing the common cold: the zinc lozenge story. Austin: George Eby Research; 1994. [accessed 18.09.09]. http://www.george-eby-research.com/html/handbook-for-curing-the-common-cold.html.
17. Eby G.A. The zinc lozenge and common cold story. Metal-ligand interactions in biological fluids: bioinorganic medicine 1995, vol. 2:1182-1190. Marcel Dekker, Inc., New York.
18. Eby G.A. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Bioscience Rep 2004, 24:23-39.
19. Eby G.A., Halcomb W.W. Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols. Med Hypotheses 1985, 17:157-165.
20. Suara R.O., Crowe J.E. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother 2004, 48:783-790.
21. Eby G.A., Davis D.R., Halcomb W.W. Reduction in duration of common colds by zinc gluconate lozenges in a double blind study. Antimicrob Agents Chemother 1984, 25:20-24.
22. Douglas R.M., Miles H.B., Moore B.W., et al. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987, 31:1263-1265.
23. Smith RM, Martell A, Motekaitis RJ. NIST critically selected stability constants of metal complexes database. Version 2. Gaithersburg: US Department of Commerce, NIST; 1995.
24. Eby G.A. Zinc ion availability - the determinant of efficacy in zinc lozenge treatment of common colds. J Antimicrob Chemother 1997, 40:483-493.
25. Eby G.A. Linearity in dose-response from zinc lozenges in treatment of common colds. J Pharm Technol 1995, 11:110-122.
26. Eby G.A. Zinc lozenges as cure for common cold. Ann Pharmacother 1996, 30:1336-1338.
27. Martin R.B. pH as a variable in free zinc ion concentration from zinc-containing lozenges (letter). Antimicrob Agents Chemother 1988, 32:608-609.
28. Eby GA. Solution chemistry determinations for: zinc acetate, zinc gluconate, zinc gluconate glycine (ZGG) and zinc gluconate-citrate. [accessed 09.09.09]. http://www.george-eby-research.com/html/solution-chemistry.html.
29. Bakar N.K.A., Taylor D.M., Williams D.R. The chemical speciation of zinc in human saliva: possible correlation with reduction of the symptoms of the common cold produced by zinc gluconate-containing lozenges. Chem Spec Bioavailab 1999, 11:95-101.
30. Zarembo J.E., Godfrey J.C., Godfrey N.J. Zinc(II) in saliva: determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. J Pharm Sci 1992, 81:128-130.
31. Cannan R.K., Kibrick A. Complex formation between carboxylic acids and divalent metal cations. J Am Chem Soc 1938, 60:2314-2320.
32. Martell A.M., Smith R.M. Critical stability constants 1982, vol. 5. Plenum Publishing Corp., New York.
33. Alemdaroglu T., Berthon G. Trace metal requirements in total parenteral nutrition II. Potentiometric study of the metal-ion equilibria in the zinc-histidine, zinc-glycine, zinc-cysteine-histinidine, zinc-glycine-histidine and zinc-glycine-cysteine systems under physiological conditions. J Electroanal Chem Interf Electrochem 1981, 128:49-62.
34. Al-Nakib W., Higgins P.G., Barrow I., et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987, 20:893-901.
35. Berthon G., Germonneau P. Histamine as a ligand in blood plasma. Part 6. Aspartate and glutamate as possible partner ligands for zinc and histamine to favor histamine catabolism. Agents Actions 1982, 12:619-629.
36. Farr B.M., Conner E.M., Betts R.F., et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987, 31:1183-1187.
37. Eby GA. Zinc lozenges as a common cold treatment. [accessed 09.09.09]. http://zinc-lozenges.com.
38. Zinc carbonate. [accessed 12.09.09]. http://www.jtbaker.com/msds/englishhtml/z1995.htm.
39. Berthon G., Varsamidis A., Blaquiere C. Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand coordination. In vitro tests on lymphocyte proliferation. Agents Actions 1987, 22:231-247.
40. Smith D.S., Helzner E.C., Nuttall C.E., et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 1989, 33:646-648.
41. Weismann K., Jakobsen J.P., Weismann J.E., et al. Zinc gluconate for common cold. A double-blind clinical trial. Dan Med Bull 1990, 37:279-281.
42. Godfrey J.C., Conant Sloane B., Smith D.S., et al. Zinc gluconate and the common cold: a controlled clinical study. J Int Med Res 1992, 20:234-246.
43. Mossad S.B., Macknin M.L., Medendorp S.V., Mason P. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Int Med 1996, 125:81-88.
44. Macknin M.L., Piedmonte M., Calendine C., et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA 1998, 279:1962-1967.
45. Petrus E.J., Lawson K.A., Bucci L.R., Blum K. Randomized, double-masked, placebo-controlled, clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res 1998, 59:595-607.
46. Prasad A.S., Fitzgerald J.T., Bao B., et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Int Med 2000, 133:245-252.
47. Turner R.B., Cetnarowski W.E. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis 2000, 31:1202-1208.
48. Eby G.A. Elimination of efficacy by additives in zinc acetate lozenges for common colds (letter). Clin Infect Dis 2001, 32:1520-1528.
49. Eby G.A., Halcomb W.W. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial. Altern Ther Health Med 2006, 12:34-38.
50. Zinc orotate (dihydrate). [accessed 12.09.09]. http://www.globalcalcium.com/06zinc_orotate.htm.
51. Gwaltney J.M. Clinical significance and pathogenesis of viral respiratory infections. Am J Med 2002, 112(Suppl. 6A):13S-18S.
52. Farr B.M., Gwaltney J.M. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. J Chron Dis 1987, 40:875-879.
53. Flynn G.L., Yalkowsky S.H., Roseman T.J. Mass transport phenomena and models: theoretical concepts. J Pharm Sci 1974, 63:479-510.
54. Nordenström B.E. Biologically closed electric circuits. Clinical, experimental and theoretical evidence for an additional circulatory system 1983, Nordic Medical Publications, Stockholm, p. 112-72.
55. Part II, formulas. In: Merck manual of the materia medica, Merck, New York; 1901. p. 125.
56. Franklin P. Treatment of hay fever by intranasal zinc ionization. BMJ 1931, 27(June):1115-1116.
57. Shields C. The zinc ionization treatment of hay fever. Practitioner 1936, (January-June):645-648.
58. Wenner Wf., Alexander Jh. Effect of zinc ionization and galvanic current on the reaction of the nasal mucosa to vasomotor drugs. Arch Otolaryngol 1936, 24:742-752.
59. Sceusa N.A., Ehrlich P.M. Proof of electro-osmotic drug delivery: a prejudiced clinical trial, delivering from mouth to nose. Drug Deliv Technol 2008, 8:50-59.
60. Eby G.A. Rescue treatment and prevention of asthma using magnesium throat lozenges: hypothesis for a mouth-lung biologically closed electric circuit. Med Hypotheses 2006, 67:1136-1141.
61. Geist F.C., Bateman J.A., Hayden F.G. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother 1987, 31:622-624.
62. Fiala M., Kenny G.E. Effect of magnesium on replication of rhinovirus HGP. J Virol 1967, 1:489-493.
63. Fiala M. Plaque formation by 55 rhinovirus serotypes. Appl Microbiol 1968, 16:1445-1450.
64. Eby G.A. Hypothesis for risk of death or serious sequela from pediatric asthmatic use of magnesium throat lozenges due to 8 to 310-fold rhinovirus release increase by concentrated magnesium. Med Hypotheses 2010, 74(1):206-207.
65. Sandstead H.H. Zinc nutrition in the United States. Am J Clin Nutr 1973, 26:1251-1260.
66. Chandra R.K. Excessive intake of zinc impairs immune responses. JAMA 1984, 252:1443-1446.
67. Nations S.P., Boyer P.J., Love L.A., Burritt M.F., Butz J.A., Wolfe G.I., et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology 2008, 71:639-643.
68. Brewer G.J. Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother 2001, 2:1473-1477.
69. Barrie S.A., Wright J.V., Pizzorno J.E., Kutter E., Barron P.C. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions 1987, 21:223-228.
70. Caruso T.J., Prober C.G., Gwaltney J.M. Treatment of naturally acquired common colds with zinc: a structured review. Clin Infect Dis 2007, 45:569-574.
71. Briggs A., Finch P., Matulewicz M.C., et al. Complexes of copper(II), calcium, and other metal ions with carbohydrates: thin-layer ligand-exchange chromatography and determination of relative stabilities of complexes. Carbohyd Res 1981, 97:181-188.
72. Goodwin J.S., Goodwin J.M. The tomato effect: rejection of highly efficacious. JAMA 1984, 251:2387-2390.
73. Barber B. Resistance by scientists to scientific discovery. Science 1961, 134:596-602.
74. Furia TE. Sequestrants in foods. In: CRC handbook of food additives. Cleveland: The Chemical Rubber Co.; 1972. p. 289-312. [Table 2. Stability Constants (logK1) of Various Metal Chelates. [accessed 22.09.09]]. http://www.george-eby-research.com/html/stability_constants.html.
75. Osol A. Astringents and antiperspirants. Remington's pharmaceutical sciences 1980, 720-723. Mack Publishing Co., Easton. 16th ed. A. Osol (Ed.).
76. Bashford C.L., Alder G.M., Menestrina G., et al. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents - a common mechanism blocked by divalent cations. J Biol Chem 1986, 261:9300-9308.
77. Lang C., Murgia C., Leong M., Tan L.W., Perozzi G., Knight D., Ruffin R., Zalewski P. Anti-inflammatory effects of zinc and alterations in zinc transporter mRNA in mouse models of allergic inflammation. Am J Physiol Lung Cell Mol Physiol 2007, 292:L577-L584.
78. Risby, TH, Prasad, AS. "Ultratrace metal analysis biological sciences and environment" advances in chemistry. Series No. 172. Washington, DC: American Chemical Society; 1979. p. 321-2.
79. Tahan F. Could zinc be protective against bronchiolitis obliterans?. Med Hypotheses 2006, 66:865.
80. Butler G.F. Astringents. Text book of materia medica, therapeutics, and pharmacology 1899, 752. Saunders, W.B. Philadelphia. 3rd ed.
81. Sandstead H.H., Prasad A.S., Penland J.G., et al. Zinc deficiency in Mexican American children: influence of zinc and other micronutrients on T cells, cytokines, and antiinflammatory plasma proteins. Am J Clin Nutr 2008, 88:1067-1073.